R. Michael Carruthers
Net Worth

Last updated:

What is R. Michael Carruthers net worth?

The estimated net worth of Mr. R. Michael Carruthers is at least $6,295,744 as of 11 Oct 2024. He owns shares worth $90,822 as insider, has earned $5,046,892 from insider trading and has received compensation worth at least $1,158,030 in Edgewise Therapeutics, Inc..

What is the salary of R. Michael Carruthers?

Mr. R. Michael Carruthers salary is $386,010 per year as Chief Financial Officer in Edgewise Therapeutics, Inc..

How old is R. Michael Carruthers?

Mr. R. Michael Carruthers is 67 years old, born in 1958.

What stocks does R. Michael Carruthers currently own?

As insider, Mr. R. Michael Carruthers owns shares in one company:

Company Title Shares Price per share Total value
Edgewise Therapeutics, Inc. (EWTX) Chief Financial Officer 6,904 $13.16 $90,822

What does Edgewise Therapeutics, Inc. do?

Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has completed Phase 1 clinical trial. It develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. Edgewise Therapeutics, Inc. was incorporated in 2017 and is headquartered in Boulder, Colorado.

EWTX logo
EWTX
Edgewise Therapeutics, Inc.
$13.16

R. Michael Carruthers insider trading

Edgewise Therapeutics, Inc.

Mr. R. Michael Carruthers has made 6 insider trades between 2022-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 96,068 units of EWTX stock on 20 Sep 2024. As of 11 Oct 2024 he still owns at least 6,904 units of EWTX stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 70,000 $0.71 $49,700
Option
Stock Option (Right to Buy) 70,000 $0.71 $49,700
Option
Common Stock 46,068 $1.93 $88,911
Sale
Common Stock 46,068 $28.59 $1,316,900
Option
Stock Option (Right to Buy) 96,068 $1.93 $185,411
Option
Common Stock 50,000 $1.93 $96,500
Sale
Common Stock 74,960 $28.57 $2,141,382
Sale
Common Stock 4,064 $28.59 $116,174
Sale
Common Stock 2,157 $18.91 $40,789
Option
Restricted Stock Units 5,208 N/A N/A
Option
Common Stock 5,208 N/A N/A
Option
Common Stock 90,000 $1.93 $173,700
Option
Stock Option (Right to Buy) 90,000 $1.93 $173,700
Sale
Common Stock 90,000 $15.78 $1,419,750
Option
Stock Options (Right to buy) 10,000 $0.71 $7,100
Option
Common Stock 10,000 $0.71 $7,100
Sale
Common Stock 1,336 $8.91 $11,897
Option
Common Stock 5,208 N/A N/A
Option
Restricted Stock Units 5,208 N/A N/A
Option
Stock Option (Right to Buy) 9,000 $0.71 $6,390
Option
Common Stock 9,000 $0.71 $6,390

Edgewise Therapeutics key executives

Edgewise Therapeutics, Inc. executives and other stock owners filed with the SEC: